Cytosorbents
CTSO
#10823
Rank
โ‚น1.44 B
Marketcap
โ‚น458.95
Share price
-9.31%
Change (1 day)
683.61%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -โ‚น1.71 Billion

According to Cytosorbents's latest financial reports the company's current earnings are โ‚น37.21 Million. In 2025 the company made an earning of -โ‚น0.82 Billion, an increase over its 2024 earnings that were of -โ‚น2.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น1.71 Billion110.92%
2025 -โ‚น0.82 Billion-62.16%
2024 -โ‚น2.15 Billion-22.49%
2023 -โ‚น2.77 Billion-13.52%
2022 -โ‚น3.2 Billion34.04%
2021 -โ‚น2.39 Billion182.17%
2020 -โ‚น0.85 Billion-55.97%
2019 -โ‚น1.92 Billion14.17%
2018 -โ‚น1.69 Billion95.14%
2017 -โ‚น0.87 Billion-22.32%
2016 -โ‚น1.11 Billion39.1%
2015 -โ‚น0.8 Billion-12.89%
2014 -โ‚น0.92 Billion89%
2013 -โ‚น0.49 Billion26.65%
2012 -โ‚น0.39 Billion-26.02%
2011 -โ‚น0.52 Billion-288.45%
2010 โ‚น0.27 B-4.17%
2009 โ‚น0.28 B-287.19%
2008 -โ‚น0.16 Billion-47.12%
2007 -โ‚น0.29 Billion41.78%
2006 -โ‚น0.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
โ‚น333.04 B-19,085.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚น73.28 B-4,277.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
โ‚น5.23 B-398.19%๐Ÿ‡บ๐Ÿ‡ธ USA